Completed

A Study of LY2875358 in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

I4C-MC-JTBF - ClinicalTrials.gov - NCT02082210

The purpose of this study is to find a recommended schedule and dose range for LY2875358 when given with ramucirumab that may be safely given to participants with cancer. In Part A of this study, escalating doses of LY2875358 will be given in combination with a fixed dose of ramucirumab to evaluate the safety of the combination. After a recommended schedule and dose range of LY2875358 and ramucirumab has been established, Part B of the study will confirm safety and to see how well certain tumors respond to the combination of study drugs.
How long will I be in the trial?
The duration of your participation depends on how well your disease responds to the study treatment and how many cycles of treatment you receive.
Email
Completed

A Study of LY2875358 in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

I4C-MC-JTBF - ClinicalTrials.gov - NCT02082210

The purpose of this study is to find a recommended schedule and dose range for LY2875358 when given with ramucirumab that may be safely given to participants with cancer. In Part A of this study, escalating doses of LY2875358 will be given in combination with a fixed dose of ramucirumab to evaluate the safety of the combination. After a recommended schedule and dose range of LY2875358 and ramucirumab has been established, Part B of the study will confirm safety and to see how well certain tumors respond to the combination of study drugs.
How long will I be in the trial?
The duration of your participation depends on how well your disease responds to the study treatment and how many cycles of treatment you receive.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Advanced Cancer, Gastroesophageal Junction Cancer (GEJ), Liver Cancer, Non-small Cell Lung Cancer, Kidney Cancer, Stomach Cancer, Esophageal Cancer

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

100

Trial Dates

March 2014 - January 2018

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Advanced Cancer, Gastroesophageal Junction Cancer (GEJ), Liver Cancer, Non-small Cell Lung Cancer, Kidney Cancer, Stomach Cancer, Esophageal Cancer

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

100

Trial Dates

March 2014 - January 2018

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?